Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics for the treatment of vaginal bacteriosis
IRCT20190202042596N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of metronidazole in bacterial vaginosis (BV) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Number of lactobacilli and Number of anaerobes. Started Jan 2020; status: completed.
02
Drugs
metronidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on IRCT20190202042596N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190202042596N1.